Beximco Pharmaceuticals Limited (LON:BXP - Get Free Report) hit a new 52-week high during trading on Monday . The stock traded as high as GBX 49 ($0.66) and last traded at GBX 49 ($0.66), with a volume of 1000 shares traded. The stock had previously closed at GBX 47.11 ($0.63).
Beximco Pharmaceuticals Stock Down 0.6%
The company has a debt-to-equity ratio of 12.47, a current ratio of 2.13 and a quick ratio of 0.37. The company has a market cap of £33.88 billion, a PE ratio of 5.33 and a beta of 0.61. The company has a fifty day moving average price of GBX 40.54 and a 200 day moving average price of GBX 38.71.
Beximco Pharmaceuticals Company Profile
(
Get Free Report)
Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Incorporated in 1976, the Company started its operation by importing products from Bayer, Germany and Upjohn, USA and selling them in the local market. In 1980, Beximco Pharma began manufacturing of these products under licensing arrangement and in 1983 launched its own formulation brands.
Featured Articles
Before you consider Beximco Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Beximco Pharmaceuticals wasn't on the list.
While Beximco Pharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access